Reproductive Health and Cystic Fibrosis: New Guidance Offers Options and Hope
Medical advancements in cystic fibrosis treatments, specifically CFTR modulators, have significantly improved patient health and fertility. This shift allows many patients to consider biological parenthood, a possibility previously thought unattainable.
Why it matters
It highlights a major breakthrough in chronic disease management that fundamentally changes the life trajectory and reproductive options for thousands of patients.
Raksha Jain, M.D., is Medical Director of the Adult Cystic Fibrosis Program and Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine at UT Southwestern Medical Center. She discusses how the latest treatment advances in cystic fibrosis have made it possible for more patients to consider having biological children.
Raksha Jain, M.D., is Medical Director of the Adult Cystic Fibrosis Program and Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine at UT Southwestern Medical Center.
By Raksha Jain, M.D. , Medical Director, Adult Cystic Fibrosis Program
Internal Medicine - Pulmonary and Critical Care Medicine , UT Southwestern Medical Center
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in